The expression levels of the Kdr gene encoding vascular endothelial growth factor receptor 2 (VEGFR2), the primary receptor of VEGFA, were similar between control and propranolol treated groups in all three tumor models tested (Fig. 2D–F). The gene discussed is VEGFA; the disease is neoplasm.